---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-282994"
form_type: "8-K"
ticker: "SPRY"
cik: "0001671858"
company_name: "ARS Pharmaceuticals, Inc."
filed_at: "2026-06-25T21:01:07+00:00"
generated_at: "2026-06-25T21:02:13.656832+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# ARS Pharma stockholders elect Class III directors, ratify EY, approve say-on-pay

## Summary
- Saqib Islam, Phillip Schneider, Laura Shawver elected as Class III directors; Schneider received 38.5M for vs 27.5M withheld.
- Ernst & Young ratified as auditor for FY2026 with 79.5M for, 102k against.
- Advisory vote on NEO compensation approved with 57.3M for, 8.1M against, 622k abstain.
- Advisory vote selects 1-year frequency for future say-on-pay votes (52.1M votes) until 2032 meeting.

## SEC filing metadata
- accession: 0001193125-26-282994
- form_type: 8-K
- ticker: SPRY
- cik: 0001671858
- company_name: ARS Pharmaceuticals, Inc.
- filed_at: 2026-06-25T21:01:07+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1671858/000119312526282994/0001193125-26-282994-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1671858/000119312526282994/d26870d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-282994
- JSON: https://secwatch.observer/filing/0001193125-26-282994.json
- Plain text: https://secwatch.observer/filing/0001193125-26-282994.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.